
High Tide Plants Flag in Europe: Acquires Majority Stake in Germany’s Remexian Pharma to Drive European Expansion
High Tide Inc. (Nasdaq: HITI), a prominent retail-forward cannabis enterprise, has successfully completed its acquisition of a 51% majority stake in Germany-based Remexian Pharma GmbH for an estimated €26.4 million. This strategic move, finalized on September 2, 2025, signifies High Tide’s definitive entry into Europe’s largest federally regulated cannabis market, establishing a robust platform for…